Proposals from a venture capitalist to DDS venture companies

Hasegawa Hiroyuki

doi:10.2745/dds.32.265

Venture capitals(VC) are investing in ventures with high growth potential providing a product and service through new technology and business model. In Japan, many ventures with a DDS (Drug delivery system) technology (DDS ventures) have established, and some of them have carried out the clinical trial of their pipeline. As a place to invest in VC, I propose the following three important points in the DDS venture business growth. 1) For the pharmaceutical company, the attractiveness as a product itself with their DDS technology is more valuable than the superiority of their DDS technology. 2) As for the DDS ventures, the manufacturing process of materials of DDS and the bulk of products with DDS becomes the big hurdle in research and development (R&D). 3) DDS ventures need to build a development strategy with a product approval and entry into the market.In trends of the open innovation in the drug discovery and development in academia or pharmaceutical companies, I recognize this situation as one of the investment opportunities and will have deep interest in ever more and want to be involved in DDS technology and drug candidates.

Proposals from a venture capitalist to DDS venture companies

Bibliographic Information

Search this article

Description

Journal

References(2)*help

Keywords

Details 詳細情報について

Export

Report a problem